Imagion Biosystems Limited
IBXXF
$0.015
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 697.00K | 1.23M | 1.76M | 2.82M | 3.87M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 697.00K | 1.23M | 1.76M | 2.82M | 3.87M |
| Cost of Revenue | 432.70K | 346.50K | 264.10K | 1.23M | 2.21M |
| Gross Profit | 264.20K | 881.00K | 1.49M | 1.58M | 1.67M |
| SG&A Expenses | 870.70K | 1.30M | 1.73M | 3.15M | 4.58M |
| Depreciation & Amortization | 7.90K | 133.10K | 258.10K | 450.70K | 644.10K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.31M | 1.78M | 2.25M | 4.84M | 7.43M |
| Operating Income | -614.50K | -549.60K | -491.80K | -2.02M | -3.56M |
| Income Before Tax | -1.41M | -1.38M | -1.36M | -2.75M | -4.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.41 | -1.38 | -1.36 | -2.75 | -4.13 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.41M | -1.38M | -1.36M | -2.75M | -4.13M |
| EBIT | -614.50K | -549.60K | -491.80K | -2.02M | -3.56M |
| EBITDA | -555.50K | -365.50K | -182.70K | -1.53M | -2.92M |
| EPS Basic | -0.01 | -0.02 | -0.04 | -0.08 | -0.13 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.02 | -0.05 | -0.08 |
| EPS Diluted | -0.01 | -0.02 | -0.04 | -0.08 | -0.13 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.02 | -0.05 | -0.08 |
| Average Basic Shares Outstanding | 517.23M | 348.53M | 179.84M | 155.29M | 130.73M |
| Average Diluted Shares Outstanding | 517.23M | 348.53M | 179.84M | 155.29M | 130.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |